Jiangsu Hualan New Pharmaceutical Material (301093.SZ): The joint evaluation and approval result of the aluminum cap and formulation for pen-type injectors has been upgraded to "A" status.
Hualan Shares (301093.SZ) announced that the aluminum cap for the company's pen-type injector has recently passed the national drug supervision and administration...
Jiangsu Hualan New Pharmaceutical Material (301093.SZ) announced that the aluminum cap for the company's prefilled syringe recently passed the technical review by the Drug Evaluation Center of the National Medical Products Administration (referred to as "CDE"). It has been shown on the CDE registration information public platform for raw materials, pharmaceutical excipients, and pharmaceutical packaging materials that the status has been changed from "joint review and approval results with formulations" to "A" status.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


